In another analysis of the SPRINT study, malignant LVH (ECG with LVH, hscTnT ≥ 14 ng/L and NTproBNP ≥ 125 pg/mL) was associated with an increased risk of ARR of HF and death (4.4%) compared to 1.2% in those without elevated biomarkers or LVH. Here, NPPB is linked to hydrops fetalis.